Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of biaryl structures in drug candidates. The piperidinylsulfonyl and trifluoromethyl groups enhance binding selectivity and metabolic stability, making it valuable in optimizing lead compounds for improved potency and pharmacokinetic properties. Commonly employed in medicinal chemistry research for targeted therapies, especially in oncology and inflammatory diseases.